Xiaojun Xu

Prof. Xiaojun Xu

China Pharmaceutical University
orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2021 in Cell Metabolism
Verified
Journal Article
Open access
SCSuzhen Chen
Suzhen Chen
XLXiaoxiao Liu
Xiaoxiao Liu
CPChao Peng
Chao Peng
CTChang Tan
Chang Tan
HSHonglin Sun
Honglin Sun
JLJunli Liu
Junli Liu
Stimulation of adipose tissue thermogenesis is regarded as a promising avenue in the treatment of obesity. However, pharmacologic engagement of this process has proven difficult. Using the Connectivity Map (CMap) approach, we identified the phytochemical hyperforin (HPF) as an anti-obesity agent. We found that HPF efficiently promoted thermogenesis by stimulating AMPK and PGC-1α via a Ucp1-dependent pathway. Using LiP-SMap (limited proteolysis-mass spectrometry) combined with a microscale thermophoresis assay and molecular docking analysis, we confirmed dihydrolipoamide S-acetyltransferase (Dlat) as a direct molecular target of HPF. Ablation of Dlat significantly attenuated HPF-mediated adipose tissue browning both in vitro and in vivo. Furthermore, genome-wide association study analysis indicated that a variation in DLAT is significantly associated with obesity in humans. These findings suggest that HPF is a promising lead compound in the pursuit of a pharmacological approach to promote energy expenditure in the treatment of obesity.

1 January 2018 in Theranostics
Verified
Journal Article
Open access
PDF file
MZMu Zhang
Mu Zhang
CQCheng Qian
Cheng Qian
ZZZu-Guo Zheng
Zu-Guo Zheng
FQFei Qian
Fei Qian
YWYanyan Wang
Yanyan Wang
XXXiaojun Xu
Xiaojun Xu
Rationale: It has been reported that peroxisome proliferator activated receptor γ (PPARγ) level decreases significantly in the brains of Alzheimer's disease (AD) patients and mice models, while the mechanism is unclear. This study aims to unravel the mechanism that amyloid β (Aβ) decreases PPARγ and attempted to discover lead compound that preserves PPARγ.

3 May 2024 in Cell Reports Medicine
Verified
Journal Article
Open access
XGXin Guan
Xin Guan
SZSitong Zhu
Sitong Zhu
JSJinqian Song
Jinqian Song
KLKui Liu
Kui Liu
MLMei Liu
Mei Liu
TPTao Pang
Tao Pang
Neuroinflammation plays a significant role in ischemic injury, which can be promoted by oxidized mitochondrial DNA (Ox-mtDNA). Cytidine/uridine monophosphate kinase 2 (CMPK2) regulates mtDNA replication, but its role in neuroinflammation and ischemic injury remains unknown. Here, we report that CMPK2 expression is upregulated in monocytes/macrophages and microglia post-stroke in humans and mice, respectively. Microglia/macrophage CMPK2 knockdown using the Cre recombination-dependent adeno-associated virus suppresses the inflammatory responses in the brain, reduces infarcts, and improves neurological outcomes in ischemic CX3CR1Cre/ERT2 mice. Mechanistically, CMPK2 knockdown limits newly synthesized mtDNA and Ox-mtDNA formation and subsequently blocks NLRP3 inflammasome activation in microglia/macrophages. Nordihydroguaiaretic acid (NDGA), as a CMPK2 inhibitor, is discovered to reduce neuroinflammation and ischemic injury in mice and prevent the inflammatory responses in primary human monocytes from ischemic patients. Thus, these findings identify CMPK2 as a promising therapeutic target for ischemic stroke and other brain disorders associated with neuroinflammation.

20 May 2020 in Autophagy
Verified
Journal Article
Closed access
ZZZu-Guo Zheng
Zu-Guo Zheng
SZSi-Tong Zhu
Si-Tong Zhu
HCHui-Min Cheng
Hui-Min Cheng
XZXin Zhang
Xin Zhang
GCGang Cheng
Gang Cheng
XXXiaojun Xu
Xiaojun Xu
SCAP (SREBF chaperone) regulates SREBFs (sterol regulatory element binding transcription factors) processing and stability, and, thus, becomes an emerging drug target to treat dyslipidemia and fatt...

1 January 2019 in Theranostics
Verified
Journal Article
Open access
PDF file
ZZZu-Guo Zheng
Zu-Guo Zheng
XZXin Zhang
Xin Zhang
XLXiao-Xiao Liu
Xiao-Xiao Liu
XJXiu-Xiu Jin
Xiu-Xiu Jin
LDLunzhi Dai
Lunzhi Dai
XXXiaojun Xu
Xiaojun Xu
Rationale: Heat shock protein 9 (HSP90) are a family of the most highly expressed cellular proteins and attractive drug targets against cancer, neurodegeneration diseases, etc. HSP90 proteins have also been suggested to be linked to lipid metabolism. However, the specific function of HSP90 paralogs, as well as the underlying molecular cascades remains largely unknown. This study aims to unravel the paralog-specific role of HSP90 in lipid metabolism and try to discover paralog-specific HSP90 inhibitors.

1 December 2019 in European Journal of Pharmacology
Verified
Journal Article
Closed access
JGJiasen Guo
Jiasen Guo
YFYinshan Fang
Yinshan Fang
FJFangxin Jiang
Fangxin Jiang
LLLian Li
Lian Li
HZHonggang Zhou
Honggang Zhou
WNWen Ning
Wen Ning